Bruno Julianne

Bruno Julianne is listed in filings as Director at Galecto, Inc.. This profile follows SEC Form 4 activity through Mar 25, 2026, including sale activity. Recent filings connect the profile to Galecto, Inc. (GLTO), Damora Therapeutics, Inc. (DMRA), and CRISPR Therapeutics AG-Common Shares (CRSP). The current snapshot covers public activity from Jun 24, 2024 to Mar 25, 2026. Reported amounts are shown as $860.1K to $898.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.